drugset / Trial / NCT01035801
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see whether IN-105 (oral insulin) is able to control increase in blood glucose after eating a meal. This study will also tell whether single tablet of IN-105 is safe for patients with Type 1 diabetes mellitus who are currently taking insulin injections.
Timeline
- Start
- 2010-08-21
- Primary completion
- 2011-03-12
- Completion
- 2011-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin Lispro | Protein / enzyme biologic | — | Other |
| Subject | Insulin Tregopil | Protein / enzyme biologic | — | Oral |